CN104140410A - 鲁比前列酮的制备方法 - Google Patents
鲁比前列酮的制备方法 Download PDFInfo
- Publication number
- CN104140410A CN104140410A CN201310170628.1A CN201310170628A CN104140410A CN 104140410 A CN104140410 A CN 104140410A CN 201310170628 A CN201310170628 A CN 201310170628A CN 104140410 A CN104140410 A CN 104140410A
- Authority
- CN
- China
- Prior art keywords
- preparation
- formula
- compound
- water
- lubiprostone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310170628.1A CN104140410B (zh) | 2013-05-09 | 2013-05-09 | 鲁比前列酮的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310170628.1A CN104140410B (zh) | 2013-05-09 | 2013-05-09 | 鲁比前列酮的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104140410A true CN104140410A (zh) | 2014-11-12 |
CN104140410B CN104140410B (zh) | 2017-12-15 |
Family
ID=51849760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310170628.1A Active CN104140410B (zh) | 2013-05-09 | 2013-05-09 | 鲁比前列酮的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104140410B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104710398A (zh) * | 2015-02-17 | 2015-06-17 | 齐鲁制药有限公司 | 鲁比前列酮的新晶型及其制备方法 |
CN105985309A (zh) * | 2015-02-06 | 2016-10-05 | 苏州朗科生物技术有限公司 | 一种高纯度鲁比前列酮化合物的制备方法 |
CN107474033A (zh) * | 2016-06-07 | 2017-12-15 | 北京深蓝海生物医药科技有限公司 | 一种精制鲁比前列酮的方法 |
US10457623B1 (en) * | 2018-07-13 | 2019-10-29 | Chirogate International Inc. | Process for the preparation of Lubiprostone and intermediates thereof |
JP2020011956A (ja) * | 2018-07-13 | 2020-01-23 | チャイロゲート インターナショナル インク.Chirogate International Inc. | ルビプロストン結晶およびその調製方法 |
CN111351867A (zh) * | 2018-12-21 | 2020-06-30 | 南京正大天晴制药有限公司 | 一种测定鲁比前列酮供试品有关物质的分析方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5290811A (en) * | 1989-11-22 | 1994-03-01 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Use of 15-keto-prostaglandin compound for improvement of encephalic function |
CN1269785A (zh) * | 1997-09-09 | 2000-10-11 | 普罗克特和甘保尔公司 | 用作fp激活剂的芳香族c16-c20-取代四氢前列腺素 |
CN101379051A (zh) * | 2006-02-07 | 2009-03-04 | 株式会社·R-技术上野 | 用于制备前列腺素衍生物的方法 |
WO2011091513A1 (en) * | 2010-01-28 | 2011-08-04 | Apotex Pharmachem Inc. | Polymorphic forms of lubiprostone |
-
2013
- 2013-05-09 CN CN201310170628.1A patent/CN104140410B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5290811A (en) * | 1989-11-22 | 1994-03-01 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Use of 15-keto-prostaglandin compound for improvement of encephalic function |
CN1269785A (zh) * | 1997-09-09 | 2000-10-11 | 普罗克特和甘保尔公司 | 用作fp激活剂的芳香族c16-c20-取代四氢前列腺素 |
CN101379051A (zh) * | 2006-02-07 | 2009-03-04 | 株式会社·R-技术上野 | 用于制备前列腺素衍生物的方法 |
WO2011091513A1 (en) * | 2010-01-28 | 2011-08-04 | Apotex Pharmachem Inc. | Polymorphic forms of lubiprostone |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105985309A (zh) * | 2015-02-06 | 2016-10-05 | 苏州朗科生物技术有限公司 | 一种高纯度鲁比前列酮化合物的制备方法 |
CN104710398A (zh) * | 2015-02-17 | 2015-06-17 | 齐鲁制药有限公司 | 鲁比前列酮的新晶型及其制备方法 |
CN107474033A (zh) * | 2016-06-07 | 2017-12-15 | 北京深蓝海生物医药科技有限公司 | 一种精制鲁比前列酮的方法 |
US10457623B1 (en) * | 2018-07-13 | 2019-10-29 | Chirogate International Inc. | Process for the preparation of Lubiprostone and intermediates thereof |
JP2020011956A (ja) * | 2018-07-13 | 2020-01-23 | チャイロゲート インターナショナル インク.Chirogate International Inc. | ルビプロストン結晶およびその調製方法 |
CN111351867A (zh) * | 2018-12-21 | 2020-06-30 | 南京正大天晴制药有限公司 | 一种测定鲁比前列酮供试品有关物质的分析方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104140410B (zh) | 2017-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104140410A (zh) | 鲁比前列酮的制备方法 | |
CN112661736B (zh) | 一种泰格列净中间体的合成方法 | |
CN110372609B (zh) | 一种噁拉戈利钠盐的纯化方法 | |
WO2009153206A2 (en) | Improved Process for the Production of Bimatoprost | |
CN107879962B (zh) | 一种格隆溴铵的制备方法 | |
CN113508120B (zh) | 制备大麻二酚的方法 | |
CN104356012B (zh) | 盐酸沙格雷酯光降解杂质的制备方法 | |
CN106986766B (zh) | 他氟前列素的制备方法 | |
CN111072499B (zh) | 一种盐酸氨溴索的合成工艺 | |
CN102010327B (zh) | (±)-2-(3-苯甲酰基)-苯基丙酸的拆分方法 | |
CN109608460A (zh) | 一种1,10-二氧亚基-2,7-二氮杂螺[4.5]癸烷-7-甲酸叔丁酯的合成方法 | |
CN115010638A (zh) | 一种奈玛特韦中间体的合成方法 | |
CN111072450B (zh) | 一种烯丙醇类衍生物的合成方法 | |
CN112679512B (zh) | 曲贝替定中间体及其制备方法 | |
CN111320664B (zh) | 一种24-胆烯烯酸乙酯的制备方法 | |
CN103601708A (zh) | 一种前列素药物杂质的制备方法 | |
CN114989060A (zh) | 一种布立西坦的制备方法 | |
CN113461643A (zh) | 一种4-甲基苯磺酸[(3-氟氧杂环丁烷-3-基)甲基]酯的合成方法 | |
CN102127061B (zh) | 一种制备6-氟-3,4-二氢-2h-1-苯并吡喃-2-环氧乙烷的改进方法 | |
WO2009011551A2 (en) | Process for the efficient preparation of 3-hydroxy pyrrolidine and derivatives thereof | |
CN111018928A (zh) | 一种天麻素半水合物的合成方法及其应用 | |
CN115260074B (zh) | 一种口服抗病毒药物Paxlovid中间体的制备方法 | |
CN104529908A (zh) | 一种瑞舒伐他汀钙的制备方法 | |
CN115504862B (zh) | 一种大麻萜酚的制备方法 | |
CN111217709A (zh) | 一种(1-氟环丙基)甲胺盐酸盐的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP LIANYUNGANG HONGCHUANG PHARMACEUTICAL Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB02 | Change of applicant information |
Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant before: Jiangsu best Pharmaceutical Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: Jiangsu best Pharmaceutical Co.,Ltd. Applicant after: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant before: JIANGSU HANSOH PHARMACEUTICAL Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160323 Address after: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant after: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Address before: 222047 Lianyungang economic and Technological Development Zone, Jiangsu Applicant before: JIANGSU HANSOH PHARMACEUTICAL GROUP Co.,Ltd. Applicant before: Lianyungang Hongchuang Pharmaceutical Co.,Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |